↓ Skip to main content

Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome

Overview of attention for article published in Diabetology & Metabolic Syndrome, March 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome
Published in
Diabetology & Metabolic Syndrome, March 2014
DOI 10.1186/1758-5996-6-47
Pubmed ID
Authors

Adriana Ferreira Grosso, Sérgio Ferreira de Oliveira, Maria de Lourdes Higuchi, Desidério Favarato, Luís Alberto de Oliveira Dallan, Protásio Lemos da Luz

Abstract

The inappropriate secretion of adipocytokines plays a critical role in chronic inflammatory states associated with obesity-linked type 2 diabetes and atherosclerosis. The pleiotropic actions of simvastatin and pioglitazone on epicardial adipose tissue (EAT) are unknown. This study assessed the anti-inflammatory actions of simvastatin and pioglitazone on EAT in patients with coronary artery disease (CAD) and metabolic syndrome (MS).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 2%
Netherlands 1 2%
Germany 1 2%
Canada 1 2%
Unknown 43 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 13%
Student > Postgraduate 6 13%
Student > Bachelor 6 13%
Student > Master 6 13%
Student > Ph. D. Student 4 9%
Other 11 23%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 18 38%
Biochemistry, Genetics and Molecular Biology 4 9%
Agricultural and Biological Sciences 4 9%
Nursing and Health Professions 2 4%
Immunology and Microbiology 2 4%
Other 6 13%
Unknown 11 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2014.
All research outputs
#20,228,193
of 22,753,345 outputs
Outputs from Diabetology & Metabolic Syndrome
#558
of 661 outputs
Outputs of similar age
#193,352
of 226,159 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#14
of 15 outputs
Altmetric has tracked 22,753,345 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 661 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,159 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.